Peptide-based Cardiovascular Therapeutics Market - The Potential Therapeutic Application of Peptides and Peptidomimetics in Cardiovascular Disease

Cardiovascular diseases are amongst the leading morbidity and mortality causes worldwide. Peptides as therapeutic agent and its development has been refrained by the pharmaceutical industry owing to its size, low stability and degradation rate. However, recent resurgence has been in action in the development of therapeutic peptides. Peptides are typically short amino acid monomer chains linked through peptide bond. They are differentiated from the proteins based on its size. Rising cardiovascular diseases prevalence such as chest pain and cardiac arrest and increasing R&D in drug therapies that are peptide-based is expected to propel growth of the global peptide-based cardiovascular therapeutics market.

To learn more about this report, request a sample copy*

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/2750

Global Peptide-based Cardiovascular Therapeutics Market-Drivers

Cardiovascular diseases being increasingly prevalent in the world is expected to accelerate growth of the global peptide-based cardiovascular therapeutics market over the forecast period. For instance, as per the 2017 report of World Health Organization (WHO), over 17.9 mn deaths were filed due to cardiovascular diseases globally in 2016.

Moreover, clinical trials and R&D of latest therapeutics based on peptide is expected to propel the global peptide-based cardiovascular therapeutics market growth over the forecast period. For instance, as per 2015 report from the National Center for Biotechnology Information (NCBI), there is a rising interest in formation of peptides in pharmaceutical development and research, with 140 therapeutics, which are peptide-based, going through clinical trial evaluation.

Global Peptide-based Cardiovascular Therapeutics Market - Restraints

Rapid peptide drug metabolism is expected to hinder growth of the global peptide-based cardiovascular therapeutics market, over the forecast period. For instance, as per the 2015 report of National Center for Biotechnology Information (NCBI), natural peptides possess poor ADME (absorption, distribution, metabolism, and excretion) properties with short half-life, rapid clearance, low solubility and low permeability.

Global Peptide-based Cardiovascular Therapeutics Market - Regional Analysis

Basis on region, the global peptide-based cardiovascular therapeutics market is divided into North America, Europe, Latin America, Asia Pacific, Africa and Middle East. North America is expected to gain a dominant share in the global peptide-based cardiovascular therapeutics market during the forecast period, due to therapeutic peptides being increasingly approved. For instance, in 2015, as per the Journal Drug Discovery Today, the U.S. Food and Drug Administration (FDA) approved over 60 therapeutic peptides.

Asia Pacific is expected to register robust growth in the global peptide-based cardiovascular therapeutics market, owing to cardiovascular diseases being increasingly prevalent in the region For instance, as per the 2017 report by National Center for Cardiovascular Diseases in China, around 290 million patients in China had cardiovascular diseases.

Tailored Information as per niche requirement:

LIMITED TIME OFFER - Hurry Up!

Exclusive offer!!! Purchase the report at a discounted rate!!!

Get Discount For Buyers UPTO 30% OFF On Any Research Report 

Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/2750

Global Peptide-based Cardiovascular Therapeutics Market - Competitive Landscape

Major players functioning in the global peptide-based cardiovascular therapeutics market are, Pfizer Inc., Fresenius Kabi USA, Apotex Holdings, Inc., AstraZeneca, Novetide Ltd., Corden Pharma GmbH, Dr. Reddy’s Laboratories Limited, and Merck & Co., Inc.

Global Peptide-based Cardiovascular Therapeutics Market - Taxonomy

The global peptide-based cardiovascular therapeutics market is divided based on of distribution channel, drug type, and region.

On The Basis of Drug Type:

• Eptifibatide
• Bivalirudin

On The Basis of By Distribution Channel:

• Online Pharmacy
• Retail Pharmacy
• Hospital Pharmacy

On The Basis of Region:

• North America
• Europe
• Latin America
• Asia Pacific
• Africa
• Middle East

Other Related Reports:

BONE DEGENERATION THERAPEUTICS MARKET ANALYSIS

PLANT-BASED CHEESE MARKET ANALYSIS

AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET ANALYSIS

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837